Merck & Co., Inc. (MRK)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
79.16-3.12 (-3.79%)
At close: 1:00PM EST
78.85 -0.31 (-0.39%)
After hours: 04:58PM EST
After hours: 04:58PM EST
Currency in USD
Valuation Measures
| Market Cap (intraday) 5 | 207.83B |
| Enterprise Value 3 | 224.26B |
| Trailing P/E | 24.71 |
| Forward P/E 1 | 11.44 |
| PEG Ratio (5 yr expected) 1 | 1.31 |
| Price/Sales (ttm) | 3.97 |
| Price/Book (mrq) | 5.81 |
| Enterprise Value/Revenue 3 | 4.26 |
| Enterprise Value/EBITDA 7 | 15.40 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.47 |
| 52-Week Change 3 | 3.20% |
| S&P500 52-Week Change 3 | 26.87% |
| 52 Week High 3 | 91.40 |
| 52 Week Low 3 | 68.44 |
| 50-Day Moving Average 3 | 80.62 |
| 200-Day Moving Average 3 | 76.11 |
Share Statistics
| Avg Vol (3 month) 3 | 15.48M |
| Avg Vol (10 day) 3 | 11.31M |
| Shares Outstanding 5 | 2.53B |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 2.52B |
| % Held by Insiders 1 | 0.07% |
| % Held by Institutions 1 | 74.62% |
| Shares Short (Nov. 14, 2021) 4 | 22.18M |
| Short Ratio (Nov. 14, 2021) 4 | 1.63 |
| Short % of Float (Nov. 14, 2021) 4 | 0.88% |
| Short % of Shares Outstanding (Nov. 14, 2021) 4 | 0.88% |
| Shares Short (prior month Oct. 14, 2021) 4 | 21.88M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 2.6 |
| Forward Annual Dividend Yield 4 | 3.28% |
| Trailing Annual Dividend Rate 3 | 2.56 |
| Trailing Annual Dividend Yield 3 | 3.11% |
| 5 Year Average Dividend Yield 4 | 2.96 |
| Payout Ratio 4 | 78.08% |
| Dividend Date 3 | Oct. 06, 2021 |
| Ex-Dividend Date 4 | Sep. 13, 2021 |
| Last Split Factor 2 | 1048:1000 |
| Last Split Date 3 | Jun. 02, 2021 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec. 30, 2020 |
| Most Recent Quarter (mrq) | Sep. 29, 2021 |
Profitability
| Profit Margin | 13.68% |
| Operating Margin (ttm) | 33.82% |
Management Effectiveness
| Return on Assets (ttm) | 12.13% |
| Return on Equity (ttm) | 26.04% |
Income Statement
| Revenue (ttm) | 52.61B |
| Revenue Per Share (ttm) | 20.79 |
| Quarterly Revenue Growth (yoy) | 20.40% |
| Gross Profit (ttm) | 34.57B |
| EBITDA | 21.06B |
| Net Income Avi to Common (ttm) | 8.46B |
| Diluted EPS (ttm) | 2.83 |
| Quarterly Earnings Growth (yoy) | 55.30% |
Balance Sheet
| Total Cash (mrq) | 10.04B |
| Total Cash Per Share (mrq) | 3.98 |
| Total Debt (mrq) | 26.44B |
| Total Debt/Equity (mrq) | 73.73 |
| Current Ratio (mrq) | 1.31 |
| Book Value Per Share (mrq) | 14.17 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 13.08B |
| Levered Free Cash Flow (ttm) | 9.87B |
